CoChat

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma

Open access
Li, Guanzhang, Wang, Di, Zhai, You, Pan, Changqing, Zhang, Jiazheng, Wang, Chen, Huang, Ruoyu, Yu, Mingchen, Li, Yiming, Liu, Xing, Liu, Yanwei, Wu, Fan, Zhao, Zheng, Hu, Huimin, Shi, Zhongfang, Kahlert, Ulf Dietrich, Jiang, Tao, Zhang, Wei · 2024 · Cell Metabolism
Cited by 232

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Patients with high ALDH1A3-expressing glioblastoma (ALDH1A3 hi GBM) show limited benefit from postoperative chemoradiotherapy. Understanding the mechanisms underlying such resistance in these patients is crucial for the development of new treatments. Here, we show that the interaction between ALDH1A3 and PKM2 enhances the latter's tetramerization and promotes lactate accumulation in glioblastoma stem cells (GSCs). By scanning the lactylated proteome in lactate-accumulating GSCs, we show that XRCC1 undergoes lactylation at lysine 247 (K247). Lactylated XRCC1 shows a stronger affinity for importin α, allowing for greater nuclear transposition of XRCC1 and enhanced DNA repair. Through high-throughput screening of a small-molecule library, we show that D34-919 potently disrupts the ALDH1A3-PKM2 interaction, preventing the ALDH1A3-mediated enhancement of PKM2 tetramerization. In vitro and in vivo treatment with D34-919 enhanced chemoradiotherapy-induced apoptosis of GBM cells. Together, our findings show that ALDH1A3-mediated PKM2 tetramerization is a potential therapeutic target to improve the response to chemoradiotherapy in ALDH1A3 hi GBM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2024.07.011

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 232

Metadata

Authors
Li, G., Wang, D., Zhai, Y., Pan, C., Zhang, J., Wang, C., Huang, R., Yu, M., Li, Y., Liu, X., Liu, Y., Wu, F., Zhao, Z., Hu, H., Shi, Z., Kahlert, U. D., Jiang, T., & Zhang, W.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2024-08
Volume
36
Issue
8
Pages
1696-1710.e10
ISSN
1550-4131 (ISSN-L)
OpenAlex
W4401364974
Cited by
232
References
11
FWCI
35.34
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. https://app.cochat.ai/papers/10.1016/j.cmet.2024.07.011
The paper
Li, G., Wang, D., Zhai, Y., Pan, C., Zhang, J., Wang, C., Huang, R., Yu, M., Li, Y., Liu, X., Liu, Y., Wu, F., Zhao, Z., Hu, H., Shi, Z., Kahlert, U. D., Jiang, T., & Zhang, W. (2024). Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma. Cell Metabolism. https://doi.org/10.1016/j.cmet.2024.07.011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.